ALECTOR INC. - COMMON STOCK
4.9200
27-9月-24 15:59:58
15 分の遅延
株式
+0.1100
+2.29%
本日の幅
4.7700 - 5.0100
ISIN
N/A
ソース
NASDAQ
-
Alector to Participate in the Stifel Healthcare Conference
08 11 2023 07:00:01 提供 Nasdaq GlobeNewswire
-
Alector Reports Third Quarter 2023 Financial Results and Provides Business Update
07 11 2023 16:05:01 提供 Nasdaq GlobeNewswire
-
07 9 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
Alector to Participate in Upcoming Healthcare Conferences
31 8 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
Alector Reports Second Quarter 2023 Financial Results and Provides Business Update
03 8 2023 16:05:01 提供 Nasdaq GlobeNewswire
-
Alector to Host Mid-Year Earnings Conference Call
27 7 2023 08:30:00 提供 Nasdaq GlobeNewswire
-
Alector to Participate in the Goldman Sachs 44th Annual Global Healthcare Conference
06 6 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
Alector Reports First Quarter 2023 Financial Results and Provides Business Update
04 5 2023 16:05:00 提供 Nasdaq GlobeNewswire
-
Alector to Participate in the BofA Securities 2023 Healthcare Conference
02 5 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
Alector to Participate in Upcoming Healthcare Conferences
01 3 2023 16:05:00 提供 Nasdaq GlobeNewswire
-
Alector Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
28 2 2023 16:05:01 提供 Nasdaq GlobeNewswire
-
Alector Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
08 12 2022 16:30:00 提供 Nasdaq GlobeNewswire
-
29 11 2022 11:05:00 提供 Nasdaq GlobeNewswire
-
Alector Reports Third Quarter 2022 Financial Results and Provides Business Update
08 11 2022 16:05:01 提供 Nasdaq GlobeNewswire
-
Alector to Participate in Upcoming Healthcare Conferences
07 11 2022 07:00:01 提供 Nasdaq GlobeNewswire
-
Alector Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
03 11 2022 16:30:00 提供 Nasdaq GlobeNewswire
-
Alector Announces Promotion of Clare Hunt to Chief People Officer
13 10 2022 08:00:01 提供 Nasdaq GlobeNewswire
-
Alector Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
06 10 2022 16:30:00 提供 Nasdaq GlobeNewswire
-
Alector Initiates Phase 1 Clinical Trial of AL044 for the Treatment of Alzheimer’s Disease (AD)
12 9 2022 07:00:00 提供 Nasdaq GlobeNewswire